Literature DB >> 29662363

Isolated ACTH deficiency in self referred patients for LOH syndrome: two case reports.

Yoshikazu Sato1, Hitoshi Tanda1, Hisao Nakajima1, Toshikazu Nitta1, Keigo Akagashi1, Tatsuo Hanzawa1, Musashi Tobe1, Kazunori Haga1, Kousuke Uchida1, Ichiya Honma1.   

Abstract

We experienced two cases of isolated ACTH deficiency (IAD) in patients self referred for late-onset hypogonadism (LOH) syndrome. IAD is secondary adrenal insufficiency due to lack of secretion of ACTH and delayed diagnosis of this rare condition may be life-threatening. The predominant symptoms of IAD, such as general malaise and weakness, resemble those of LOH syndrome creating the possibility that IAD may be referred as LOH syndrome. Two middle aged men with severe general malaise visited our clinic requesting evaluation for LOH syndrome. Previous treatments had been ineffective and based on varying incorrect diagnoses by previous doctors. The patients self referred themselves for LOH syndrome. Some of their symptoms were consistent with LOH syndrome but others were atypical, in particular, the severity of malaise and appetite loss. Hormonal assays were compatible with adrenal insufficiency secondary to ACTH deficiency. Steroid replacement dramatically improved their symptoms. The clinical course of our two patients and points of differential diagnosis between IAD and LOH syndrome are reported here.

Entities:  

Keywords:  Adrenal insufficiency; General malaise; Hypotension; Isolated ACTH deficiency; LOH syndrome

Year:  2012        PMID: 29662363      PMCID: PMC5892979          DOI: 10.1007/s12522-012-0121-1

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  9 in total

1.  Isolated adrenocorticotropin deficiency and flexion contractures syndrome.

Authors:  Vassiliki Syriou; Anestis Moisidis; Nikolaos Tamouridis; Krystallenia I Alexandraki; Margarita Anapliotou
Journal:  Hormones (Athens)       Date:  2008 Oct-Dec       Impact factor: 2.885

2.  Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.

Authors:  Christina Wang; Eberhard Nieschlag; Ronald Swerdloff; Hermann M Behre; Wayne J Hellstrom; Louis J Gooren; Jean M Kaufman; Jean-Jacques Legros; Bruno Lunenfeld; Alvaro Morales; John E Morley; Claude Schulman; Ian M Thompson; Wolfgang Weidner; Frederick C W Wu
Journal:  Eur Urol       Date:  2008-08-30       Impact factor: 20.096

Review 3.  Lymphocytic adenohypophysitis and lymphocytic infundibuloneurohypophysitis.

Authors:  K Hashimoto; T Takao; S Makino
Journal:  Endocr J       Date:  1997-02       Impact factor: 2.349

Review 4.  Isolated corticotrophin deficiency.

Authors:  Massimiliano Andrioli; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 5.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

6.  Isolated ACTH deficiency and primary hypothyroidism.

Authors:  M J Miller; T V Horst
Journal:  Acta Endocrinol (Copenh)       Date:  1982-04

Review 7.  Isolated corticotropin deficiency in adults. Report of 10 cases and review of literature.

Authors:  T Yamamoto; J Fukuyama; K Hasegawa; M Sugiura
Journal:  Arch Intern Med       Date:  1992-08

8.  Prevalence of major depressive disorder in self-referred patients in a late onset hypogonadism clinic.

Authors:  Y Sato; H Tanda; S Kato; S Onishi; H Nakajima; A Nanbu; T Nitta; M Koroku; K Akagashi; T Hanzawa
Journal:  Int J Impot Res       Date:  2007-04-26       Impact factor: 2.896

Review 9.  The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.

Authors:  Abdulmaged M Traish; Andre Guay; Robert Feeley; Farid Saad
Journal:  J Androl       Date:  2008-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.